À propos de la propriété intellectuelle Formation en propriété intellectuelle Respect de la propriété intellectuelle Sensibilisation à la propriété intellectuelle La propriété intellectuelle pour… Propriété intellectuelle et… Propriété intellectuelle et… Information relative aux brevets et à la technologie Information en matière de marques Information en matière de dessins et modèles industriels Information en matière d’indications géographiques Information en matière de protection des obtentions végétales (UPOV) Lois, traités et jugements dans le domaine de la propriété intellectuelle Ressources relatives à la propriété intellectuelle Rapports sur la propriété intellectuelle Protection des brevets Protection des marques Protection des dessins et modèles industriels Protection des indications géographiques Protection des obtentions végétales (UPOV) Règlement extrajudiciaire des litiges Solutions opérationnelles à l’intention des offices de propriété intellectuelle Paiement de services de propriété intellectuelle Décisions et négociations Coopération en matière de développement Appui à l’innovation Partenariats public-privé Outils et services en matière d’intelligence artificielle L’Organisation Travailler avec nous Responsabilité Brevets Marques Dessins et modèles industriels Indications géographiques Droit d’auteur Secrets d’affaires Académie de l’OMPI Ateliers et séminaires Application des droits de propriété intellectuelle WIPO ALERT Sensibilisation Journée mondiale de la propriété intellectuelle Magazine de l’OMPI Études de cas et exemples de réussite Actualités dans le domaine de la propriété intellectuelle Prix de l’OMPI Entreprises Universités Peuples autochtones Instances judiciaires Ressources génétiques, savoirs traditionnels et expressions culturelles traditionnelles Économie Égalité des genres Santé mondiale Changement climatique Politique en matière de concurrence Objectifs de développement durable Technologies de pointe Applications mobiles Sport Tourisme PATENTSCOPE Analyse de brevets Classification internationale des brevets Programme ARDI – Recherche pour l’innovation Programme ASPI – Information spécialisée en matière de brevets Base de données mondiale sur les marques Madrid Monitor Base de données Article 6ter Express Classification de Nice Classification de Vienne Base de données mondiale sur les dessins et modèles Bulletin des dessins et modèles internationaux Base de données Hague Express Classification de Locarno Base de données Lisbon Express Base de données mondiale sur les marques relative aux indications géographiques Base de données PLUTO sur les variétés végétales Base de données GENIE Traités administrés par l’OMPI WIPO Lex – lois, traités et jugements en matière de propriété intellectuelle Normes de l’OMPI Statistiques de propriété intellectuelle WIPO Pearl (Terminologie) Publications de l’OMPI Profils nationaux Centre de connaissances de l’OMPI Série de rapports de l’OMPI consacrés aux tendances technologiques Indice mondial de l’innovation Rapport sur la propriété intellectuelle dans le monde PCT – Le système international des brevets ePCT Budapest – Le système international de dépôt des micro-organismes Madrid – Le système international des marques eMadrid Article 6ter (armoiries, drapeaux, emblèmes nationaux) La Haye – Le système international des dessins et modèles industriels eHague Lisbonne – Le système d’enregistrement international des indications géographiques eLisbon UPOV PRISMA UPOV e-PVP Administration UPOV e-PVP DUS Exchange Médiation Arbitrage Procédure d’expertise Litiges relatifs aux noms de domaine Accès centralisé aux résultats de la recherche et de l’examen (WIPO CASE) Service d’accès numérique aux documents de priorité (DAS) WIPO Pay Compte courant auprès de l’OMPI Assemblées de l’OMPI Comités permanents Calendrier des réunions WIPO Webcast Documents officiels de l’OMPI Plan d’action de l’OMPI pour le développement Assistance technique Institutions de formation en matière de propriété intellectuelle Mesures d’appui concernant la COVID-19 Stratégies nationales de propriété intellectuelle Assistance en matière d’élaboration des politiques et de formulation de la législation Pôle de coopération Centres d’appui à la technologie et à l’innovation (CATI) Transfert de technologie Programme d’aide aux inventeurs WIPO GREEN Initiative PAT-INFORMED de l’OMPI Consortium pour des livres accessibles L’OMPI pour les créateurs WIPO Translate Speech-to-Text Assistant de classification États membres Observateurs Directeur général Activités par unité administrative Bureaux extérieurs Avis de vacance d’emploi Achats Résultats et budget Rapports financiers Audit et supervision
Arabic English Spanish French Russian Chinese
Lois Traités Jugements Parcourir par ressort juridique

Équateur

EC035

Retour

Executive Decree No. 118 on Declaration of Public Interest Regarding Access to Medicines for Human Use

Executive Decree No. 118 on Declaration of Public Interest Regarding Access to Medicines for Human Use

No. 118
RAFAEL CORREA DELGADO CONSTITUTIONAL PRESIDENT OF THE REPUBLIC Courtesy translation provided by WIPO © 2012
WHEREAS:
under Article 32 of the Constitution of the Republic, health is a right guaranteed by the State and its realization is linked to the exercise of other rights that provide support for collective wellbeing;
under Article 3.1 of the Constitution of the Republic, the State has a fundamental duty to guarantee, without any discrimination whatsoever, the effective enjoyment of the rights established in the Constitution and in international instruments, in particular, rights recognized by the Constitution, such as health;
under article 363(7) of the Constitution of the Republic, in order to establish
the collective wellbeing regime, in the field of health the State is duty-bound to
“guarantee the availability of and access to safe and effective quality medicines, regulate their marketing, and promote the national production and use of generic drugs that meet the epidemiological needs of the population. With respect to access to medicines, public health interests shall prevail over economic and commercial interests.”;
Article 31 of the standards concerning the availability, scope and use of Intellectual Property Rights contained in the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement of the World Trade Organization (WTO) recognizes the right of countries to issue compulsory licenses for medicine patents which may serve to combat and mitigate the effects of diseases of public interest;
the Doha Declaration on the TRIPS Agreement and Public Health, unanimously adopted by the Members of the World Trade Organization, specifies that each Member “has the right to grant compulsory licenses and the freedom to determine the grounds upon which such licenses are granted”. Furthermore,

1

the above-mentioned Declaration states that the TRIPS Agreement should be interpreted and implemented to “promote access to medicines for all”;
Paragraph 20 of the Global strategy and plan of action on public health, innovation and intellectual property, WHA 61.21, of the World Health Assembly states that “Intellectual property rights do not and should not prevent Member States from taking measures to protect public health.”;
Objective No. 3 of the National Development Plan 2007-2010, enacted through Executive Decree 745 of April 7, 2008, is: “To increase the life expectancy and improve the quality of life of the population”;
the Andean Standard provided for in Decision 486, which establishes the Common Intellectual Property Regime, makes provision for a Compulsory Licensing Regime, as does Ecuador’s Law on Intellectual Property;
in order to meet this objective, the above-mentioned National Development Plan establishes policy 3.3 “To ensure universal access to essential medicines, strengthening State authority and sovereignty in the management of medicines and herbal remedies”, one of the strategies being the use of compulsory licenses as an instrument for reducing the cost of medicines;
it is in the State’s interest, in the field of public health, to safeguard equitable access to healthcare and consequently to medicines, in particular for the most vulnerable social and economic groups.
exercising the powers conferred by indents 1 and 3 of Article 147 of the Constitution of the Republic and the provisions of Article 65 of Decision 486 of the Andean Community of Nations:
DECREES:
Article 1.- Declaring of public interest access to medicines used in the treatment of diseases which affect the Ecuadorian population and which constitute a priority in terms of public health, and consequently authorizing the issuing of compulsory licenses for patents for medicines for use on human beings which are necessary for their treatment. Cosmetic and aesthetic medicines and bathroom products and, in general, those medicines that are not used to treat diseases, shall not be deemed to be a public health priority.

2

Article 2.- The Ecuadorian Institute of Intellectual Property (IEPI), through the National Directorate of Industrial Property, is the competent national office for granting compulsory licenses to applicants, on the condition that they meet
the requirements laid out in the relevant legislation and in this Decree.
Authorization of compulsory licenses shall be considered depending on the specific circumstances and grounds must be provided in each case. IEPI shall grant compulsory licenses in coordination with the Ministry of Public Health.
Article 3.- The “Leopoldo Izquieta Pérez” National Institute of Hygiene and Tropical Medicine shall take the necessary steps in order to grant registration for medicines produced or imported under the compulsory licensing regime, within a maximum of 30 days as of the filing of the application, on the condition that they meet the legal requirements and necessary procedures for the verification of their quality, safety and effectiveness.
Article 4.- the Ecuadorian Institute of Intellectual Property (IEPI), through the National Directorate of Industrial Property, shall establish the scope, object and time period for which the license is granted, as well as the amount and conditions of payment of the royalties of said license and other conditions specified in the relevant standard.
Article 5.- the Ecuadorian Institute of Intellectual Property (IEPI), through the National Directorate of Industrial Property, in accordance with the provisions of the relevant legislation, shall notify patent holders who are subject to the compulsory licensing regime.
Article 6.- the period of duration of the compulsory license shall be set by the competent body of the Ecuadorian Institute of Intellectual Property (IEPI). This period of duration may be declared at an end by the same authority on the condition that the legitimate interests of the persons who have received authorization for such licenses are adequately protected and if the circumstances that gave rise to the licenses no longer exist and it is improbable that those circumstances will arise again.
General provision.- the Ministry of Public Health and the Ecuadorian Institute of Intellectual Property shall be responsible for the implementation of the present Decree, depending on the scope of their competency.

3

Final provision.- The present Decree shall enter into force as of its signing, without prejudice to its publication in the Official Register.
Done at San Francisco de Quito, on October 23, 2009. Signature
RAFAEL CORREA DELGADO
CONSTITUTIONAL PRESIDENT OF THE REPUBLIC

4